Shortening trinucleotide repeats using highly specific endonucleases: a possible approach to gene therapy? - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Trends in Genetics Année : 2015

Shortening trinucleotide repeats using highly specific endonucleases: a possible approach to gene therapy?

Résumé

Trinucleotide repeat expansions are involved in more than two dozen neurological and developmental disorders. Conventional therapeutic approaches aimed at regulating the expression level of affected genes, which rely on drugs, oligonucleotides, and/or transgenes, have met with only limited success so far. An alternative approach is to shorten repeats to non-pathological lengths using highly specific nucleases. Here, I review early experiments using meganucleases, zinc-finger nucleases (ZFN), and transcription-activator like effector nucleases (TALENs) to contract trinucleotide repeats, and discuss the possibility of using CRISPR-Cas nucleases to the same end. Although this is a nascent field, I explore the possibility of designing nucleases and effectively delivering them in the context of gene therapy.
Fichier principal
Vignette du fichier
TIG-HAL.pdf (9.84 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

pasteur-01370705 , version 1 (23-09-2016)

Identifiants

Citer

Guy-Franck Richard. Shortening trinucleotide repeats using highly specific endonucleases: a possible approach to gene therapy?. Trends in Genetics, 2015, 31 (4), pp.177 - 186. ⟨10.1016/j.tig.2015.02.003⟩. ⟨pasteur-01370705⟩
449 Consultations
661 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More